Mr. Ray Doyle:

I could not agree with the Deputy more. The regulation itself actually uses the term. There has to be increased availability to farmers of antiparasitic products. We believe this will be completely counter to that - it will narrow the channels so much that there will not be increased availability. The Deputy just outlined the realities that we feel have already happened with intramammaries. Pressure will be put, intended or otherwise, to purchase off the channel that has been prescribed. The thrust of the argument we have is that this thing will be counter to the regulation itself, never mind competition. Competition will be decreased as a result but availability, which is in the regulation itself, will be decreased too.